India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
India’s Pharmaceutical Sector
Read More
October 31, 2026
- Omron Healthcare Begins Production at Chennai Plant, Targets 3 Million BP Monitors Annually by 2028
- Livasa Hospitals Expands into Haryana with 200-Plus Bed Facility in Karnal
- Centre Reviews Faculty Vacation Rules at Government Medical Colleges, Seeks Hospital Performance Data
- Maharashtra Nurses Federation Demands Inquiry into GNM Exam Irregularities, Announces Protest on October 30